EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Extended field radiation therapy vs. delayed hormonal therapy in node positive prostatic adeno carcinoma


Journal of Urology 127(5): 935-937
Extended field radiation therapy vs. delayed hormonal therapy in node positive prostatic adeno carcinoma
The disease control and survival advantage of either extended field megavoltage irradiation or delayed androgen ablation in a randomized [human] clinical trial were determined. Comparison of the 2 treatments, using either time to 1st evidence of treatment failure or survival, demonstrates an advantage to extended field radiation.


Accession: 005432587



Related references

Extended field radiation therapy versus delayed hormonal therapy in node positive prostatic adenocarcinoma. Journal of Urology 127(5): 935-937, 1982

Extended-field radiation therapy for prostatic carcinoma with para-aortic lymph node metastasis. American Journal of Clinical Oncology 9(4): 302-306, 1986

Investigation of different combinations of estrogen therapy and radiation therapy on prostatic adeno carcinoma r 3327. Urology 15(5): 443-447, 1980

The use of combined radiation therapy and hormonal therapy in the management of lymph node-positive prostate cancer. International Journal of Radiation Oncology Biology Physics 39(3): 673-680, 1997

External radiation therapy of prostatic carcinoma and its relationship to hormonal therapy. Radiation Medicine 13(6): 297-300, 1995

Chemo therapy and radiation of nb rat prostatic adeno carcinoma nb pr a 1 1. Journal of Surgical Research 28(6): 492-496, 1980

Delayed and late regression of bone metastases during endocrine therapy of prostatic adeno carcinoma. Proceedings Of The American Association For Cancer Research & American Society Of Clinical Oncology: 2, 1981

Hormonal therapy of prostatic carcinoma: is there a rationale for delayed treatment?. Urology 27(3): 199-204, 1986

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology 45(4): 616-623, 1995

Combined hormonal and radiation therapy for prostatic carcinoma. Strahlentherapie und Onkologie 167(9): 523-529, 1991